Acorda Therapeutics announced last week that it has received U.S. Food and Drug Administration (FDA) approval for Ampyra, a drug shown to improve walking in multiple sclerosis (MS) patients with...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)